Search research articles
Contact Us
Filters
Showing results (161-170 of 217) with videos related to
Page
of 22
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 4, 2003
Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results
Frederick F Lang, Janet M Bruner, Gregory N Fuller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 18, 2017
Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE
Brian M Alexander, Sujuan Ba, Mitchel S Berger, et al.
Plos One
|
March 12, 2014
Molecular subtypes of glioblastoma are relevant to lower grade glioma
Xiaowei Guan, Jaime Vengoechea, Siyuan Zheng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 20, 2005
Phase I trial of tipifarnib in patients with recurrent malignant glioma taking enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study
Timothy F Cloughesy, John Kuhn, H Ian Robins, et al.
Molecular Cancer Therapeutics
|
March 31, 2019
Prospective Clinical Sequencing of Adult Glioma
Siyuan Zheng, Kristin Alfaro-Munoz, Wei Wei, et al.
Neuro-Oncology
|
October 15, 2014
Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD)
Patrick Y Wen, Timothy F Cloughesy, Benjamin M Ellingson, et al.
Neuro-Oncology
|
March 5, 2008
A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies
Morris D Groves, Michael J Glantz, Marc C Chamberlain, et al.
Neuro-Oncology
|
June 19, 2008
Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor Consortium
Susan M Chang, Kathleen R Lamborn, John G Kuhn, et al.
Journal of the National Cancer Institute
|
November 3, 2005
Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance
Marta M Alonso, Juan Fueyo, Jerry W Shay, et al.
Neuro-Oncology
|
March 4, 2008
Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme
Vinay K Puduvalli, Pierre Giglio, Morris D Groves, et al.
Page
of 22
Search research articles
Search
Showing results (161-170 of 217) with videos related to
Sort By:
Page
of 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 4, 2003
Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results
Frederick F Lang, Janet M Bruner, Gregory N Fuller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 18, 2017
Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE
Brian M Alexander, Sujuan Ba, Mitchel S Berger, et al.
Plos One
|
March 12, 2014
Molecular subtypes of glioblastoma are relevant to lower grade glioma
Xiaowei Guan, Jaime Vengoechea, Siyuan Zheng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 20, 2005
Phase I trial of tipifarnib in patients with recurrent malignant glioma taking enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study
Timothy F Cloughesy, John Kuhn, H Ian Robins, et al.
Molecular Cancer Therapeutics
|
March 31, 2019
Prospective Clinical Sequencing of Adult Glioma
Siyuan Zheng, Kristin Alfaro-Munoz, Wei Wei, et al.
Neuro-Oncology
|
October 15, 2014
Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD)
Patrick Y Wen, Timothy F Cloughesy, Benjamin M Ellingson, et al.
Neuro-Oncology
|
March 5, 2008
A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies
Morris D Groves, Michael J Glantz, Marc C Chamberlain, et al.
Neuro-Oncology
|
June 19, 2008
Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor Consortium
Susan M Chang, Kathleen R Lamborn, John G Kuhn, et al.
Journal of the National Cancer Institute
|
November 3, 2005
Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance
Marta M Alonso, Juan Fueyo, Jerry W Shay, et al.
Neuro-Oncology
|
March 4, 2008
Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme
Vinay K Puduvalli, Pierre Giglio, Morris D Groves, et al.
Page
of 22